Cowen and Company set a $24.00 target price on NCI, Inc. (NASDAQ:NCIT) in a report published on Thursday, June 8th. The firm currently has a buy rating on the information technology services provider’s stock.
Several other research firms have also weighed in on NCIT. Noble Financial reissued a buy rating on shares of NCI in a research note on Friday, May 12th. Zacks Investment Research upgraded NCI from a sell rating to a hold rating in a report on Saturday, May 13th. FBR & Co reiterated a hold rating and set a $11.00 price objective on shares of NCI in a report on Tuesday, April 4th. Finally, ValuEngine upgraded NCI from a hold rating to a buy rating in a research note on Friday, June 2nd. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. The stock has an average rating of Buy and a consensus target price of $17.50.
Shares of NCI (NCIT) opened at 20.30 on Thursday. The stock has a market cap of $275.09 million, a P/E ratio of 45.41 and a beta of 0.98. NCI has a 52-week low of $10.98 and a 52-week high of $21.00. The company has a 50-day moving average of $18.39 and a 200 day moving average of $15.07.
NCI (NASDAQ:NCIT) last issued its quarterly earnings results on Tuesday, May 9th. The information technology services provider reported $0.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.21 by $0.04. NCI had a return on equity of 11.73% and a net margin of 2.13%. The business had revenue of $78.75 million for the quarter, compared to analyst estimates of $76.55 million. Equities research analysts forecast that NCI will post $1.01 EPS for the current fiscal year.
COPYRIGHT VIOLATION WARNING: This news story was originally reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this news story on another publication, it was illegally copied and reposted in violation of US and international trademark and copyright law. The legal version of this news story can be accessed at https://sportsperspectives.com/2017/06/21/nci-inc-ncit-given-a-24-00-price-target-at-cowen-and-company-updated.html.
A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Algert Global LLC increased its position in shares of NCI by 10.8% in the first quarter. Algert Global LLC now owns 12,155 shares of the information technology services provider’s stock valued at $183,000 after buying an additional 1,180 shares during the last quarter. Hancock Holding Co. acquired a new position in shares of NCI during the first quarter worth about $189,000. Teachers Advisors LLC increased its position in shares of NCI by 44.1% in the fourth quarter. Teachers Advisors LLC now owns 13,212 shares of the information technology services provider’s stock worth $184,000 after buying an additional 4,044 shares in the last quarter. ClariVest Asset Management LLC increased its position in shares of NCI by 5.3% in the first quarter. ClariVest Asset Management LLC now owns 14,464 shares of the information technology services provider’s stock worth $217,000 after buying an additional 727 shares in the last quarter. Finally, Russell Investments Group Ltd. acquired a new position in shares of NCI during the fourth quarter worth about $216,000. 39.04% of the stock is currently owned by hedge funds and other institutional investors.
NCI Company Profile
NCI, Inc is a provider of enterprise services and solutions to defense, intelligence, healthcare and civilian government agencies. The Company provides information technology (IT), and professional services and solutions by leveraging its core service offerings, which include cloud computing and IT infrastructure optimization; cybersecurity and information assurance; engineering and logistics support; enterprise information management and advanced analytics; health IT and medical support; IT service management; modeling, simulation, and training, and agile development and integration.
Receive News & Ratings for NCI Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NCI Inc. and related companies with MarketBeat.com's FREE daily email newsletter.